Literature DB >> 21783181

CT features and quantification of the characteristics of adrenocortical carcinomas on unenhanced and contrast-enhanced studies.

H M Zhang1, N D Perrier, E G Grubbs, K Sircar, Z X Ye, J E Lee, C S Ng.   

Abstract

AIM: To describe the morphological and contrast-agent washout characteristics of adrenocortical carcinomas (ACCs) on computed tomography (CT).
MATERIALS AND METHODS: Forty-one patients with histopathologically proven ACCs were retrospectively evaluated. The morphological characteristics of the ACCs were documented and compared with surgical and histopathological findings. The percentage of contrast agent enhancement washout (PEW) and relative PEW (RPEW) were calculated for 17 patients who had the combination of unenhanced, portal venous, and 15 min delayed phase images.
RESULTS: Characteristic imaging findings of ACCs included large size (38 of 41 tumours were >6 cm), well-defined margin with a thin enhancing rim (25 patients), and central stellate area of low attenuation on contrast-enhanced CT images (21 patients). Tumour extension into the inferior vena cava (IVC) with associated thrombus was identified on CT in six (14.6%) patients. Of 17 tumours evaluated, 12 (71%) had a PEW value of ≤60%, and 14 (82%) had an RPEW value of ≤40%.
CONCLUSION: Large size, a well-defined margin with a thin enhancing rim, central low attenuation, and a predilection for extension into the IVC are typical morphological characteristics of ACC on CT. The contrast-washout characteristics of ACCs, in concordance with their malignant nature, share those of non-adenomas rather than adenomas.
Copyright © 2011 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21783181      PMCID: PMC3889671          DOI: 10.1016/j.crad.2011.03.023

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  32 in total

1.  Hanson lecture. Adrenal imaging: current status.

Authors:  N R Dunnick
Journal:  AJR Am J Roentgenol       Date:  1990-05       Impact factor: 3.959

Review 2.  Adrenocortical cancer.

Authors:  Melissa Wandoloski; Kimberly J Bussey; Michael J Demeure
Journal:  Surg Clin North Am       Date:  2009-10       Impact factor: 2.741

3.  Imaging findings in pediatric adrenocortical carcinoma.

Authors:  J Ribeiro; R C Ribeiro; B D Fletcher
Journal:  Pediatr Radiol       Date:  2000-01

4.  Adrenocortical carcinoma with fat inclusion: case report.

Authors:  S Heye; H Woestenborghs; F Van Kerkhove; R Oyen
Journal:  Abdom Imaging       Date:  2005 Sep-Oct

Review 5.  Adrenocortical carcinoma: clinical and laboratory observations.

Authors:  B L Wajchenberg; M A Albergaria Pereira; B B Medonca; A C Latronico; P Campos Carneiro; V A Alves; M C Zerbini; B Liberman; G Carlos Gomes; M A Kirschner
Journal:  Cancer       Date:  2000-02-15       Impact factor: 6.860

6.  Adrenal masses: characterization with combined unenhanced and delayed enhanced CT.

Authors:  Elaine M Caoili; Melvyn Korobkin; Isaac R Francis; Richard H Cohan; Joel F Platt; N Reed Dunnick; Kartik I Raghupathi
Journal:  Radiology       Date:  2002-03       Impact factor: 11.105

7.  A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology.

Authors:  F Mantero; M Terzolo; G Arnaldi; G Osella; A M Masini; A Alì; M Giovagnetti; G Opocher; A Angeli
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

Review 8.  Adrenocortical cancer treatment.

Authors:  A Patalano; V Brancato; F Mantero
Journal:  Horm Res       Date:  2009-01-21

9.  Helical CT evaluation of the preoperative staging of gastric cancer in the remnant stomach.

Authors:  In Joon Lee; Jeong Min Lee; Se Hyung Kim; Samuel Chang; Joon Koo Han; Byung Ihn Choi; Hyuk-Joon Lee; Han-Kwang Yang; Kuhn Uk Lee
Journal:  AJR Am J Roentgenol       Date:  2009-04       Impact factor: 3.959

10.  18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients.

Authors:  Lionel Groussin; Gérald Bonardel; Stéphane Silvéra; Frédérique Tissier; Joël Coste; Gwenaelle Abiven; Rossella Libé; Marie Bienvenu; Jean-Louis Alberini; Sylvie Salenave; Philippe Bouchard; Jérôme Bertherat; Bertrand Dousset; Paul Legmann; Bruno Richard; Hervé Foehrenbach; Xavier Bertagna; Florence Tenenbaum
Journal:  J Clin Endocrinol Metab       Date:  2009-02-03       Impact factor: 5.958

View more
  10 in total

1.  Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE).

Authors:  A Stigliano; I Chiodini; R Giordano; A Faggiano; L Canu; S Della Casa; P Loli; M Luconi; F Mantero; M Terzolo
Journal:  J Endocrinol Invest       Date:  2015-07-14       Impact factor: 4.256

2.  Unilateral adrenal tuberculosis whose computed tomography imaging characteristics mimic a malignant tumor: A case report.

Authors:  Hui Liu; Tian-Jiao Tang; Zhen-Mei An; Ye-Rong Yu
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

3.  Role of Additional Organ Resection in Adrenocortical Carcinoma: Analysis of 167 Patients from the U.S. Adrenocortical Carcinoma Database.

Authors:  Paula Marincola Smith; Colleen M Kiernan; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Jason Prescott; Timothy Pawlik; Tracy S Wang; Jason Glenn; Ioannis Hatzaras; Rivka Shenoy; John Phay; Lawrence A Shirley; Ryan C Fields; Linda Jin; Sharon Weber; Ahmed Salem; Jason Sicklick; Shady Gad; Adam Yopp; John Mansour; Quan-Yang Duh; Natalie Seiser; Konstantinos Votanopoulos; Edward A Levine; George Poultsides; Carmen C Solórzano
Journal:  Ann Surg Oncol       Date:  2018-06-04       Impact factor: 5.344

4.  Adrenocortical carcinoma: modern management and evolving treatment strategies.

Authors:  Lucas A McDuffie; Rachel D Aufforth
Journal:  Int J Endocr Oncol       Date:  2016-04-08

5.  18F-FDG-PET/CT Evaluation of Indeterminate Adrenal Masses in Noncancer Patients.

Authors:  Xin He; Elaine M Caoili; Anca M Avram; Barbra S Miller; Tobias Else
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

Review 6.  Incidental Adrenal Nodules and Masses: The Imaging Approach.

Authors:  J Willatt; S Chong; J A Ruma; J Kuriakose
Journal:  Int J Endocrinol       Date:  2015-04-29       Impact factor: 3.257

Review 7.  Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment.

Authors:  Rossella Libé
Journal:  Front Cell Dev Biol       Date:  2015-07-03

Review 8.  Diagnostic and prognostic features in adrenocortical carcinoma: a single institution case series and review of the literature.

Authors:  Kerollos N Wanis; Rani Kanthan
Journal:  World J Surg Oncol       Date:  2015-03-24       Impact factor: 2.754

9.  Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases.

Authors:  Cheuk-Lik Wong; Chun-Kit Fok; Yuk-Kit Chan; Vicki Ho-Kee Tam; Lai-Ming Fung
Journal:  Case Rep Endocrinol       Date:  2022-09-14

Review 10.  Open versus minimally invasive surgery for suspected adrenocortical carcinoma.

Authors:  Dylan M Buller; Alex M Hennessey; Benjamin T Ristau
Journal:  Transl Androl Urol       Date:  2021-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.